Watchman Laa denied due to quantity / dose limits by Cigna?

Cigna's specific coverage criteria for watchman laa are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why Cigna Limits Watchman LAA Coverage — and How to Appeal

The Watchman Left Atrial Appendage (LAA) closure device is a permanent implant indicated for patients with non-valvular atrial fibrillation who need an alternative to long-term anticoagulation. Because it is a single-use, one-per-lifetime implant, Cigna's quantity-limit policy is typically structured to allow one device per patient lifetime. A denial on quantity-limit grounds most often arises when administrative records show a prior implant, when a reintervention or replacement is requested, or when coding errors make it appear that a second primary device is being sought.

## Why This Denial Is Appealable

Quantity-limit denials are medical decisions and are subject to the same full appeal rights as any other coverage determination. Under ACA Section 2719 (for non-grandfathered group and individual plans), you have the right to an independent external review after exhausting internal appeals. Under ERISA Section 503, employer-sponsored plan members are entitled to a full-and-fair internal review with a written explanation of every clinical and policy basis for the denial. The external-review window is generally 180 days from the date of the denial notice; an expedited (72-hour) external review is available when a standard timeline would seriously jeopardize life or health.

## Concrete Appeal Steps

1. Request the denial rationale in writing. The denial letter must cite the specific quantity-limit provision and any clinical criteria applied. 2. Obtain Cigna's published medical coverage policy for the Watchman device and read the quantity-limit section verbatim. Compare it against your actual clinical situation. 3. File the internal appeal within the plan's stated deadline (usually 180 days from denial). Submit a written request and keep a timestamped copy. 4. If the internal appeal is denied, request external review through your state's independent review organization or the federal external-review process.

## Documentation to Gather

• Diagnosis confirmation: Current atrial fibrillation diagnosis with date of onset, rhythm documentation, and stroke-risk stratification documented in the chart.
• Prior-treatment history: Complete anticoagulation history — agents tried, dates, doses, and the specific reason each was discontinued (bleeding event, allergy, patient-specific contraindication per the treating clinician's note).
• Clinical severity: Chart documentation of bleeding history, fall risk, or other factors that make long-term anticoagulation unsuitable for this specific patient.
• Prescriber medical-necessity letter: A signed letter from the implanting electrophysiologist or cardiologist explaining why this patient meets the indications in the FDA-approved labeling for the Watchman device and why the quantity-limit exception applies (e.g., prior device malfunction requiring replacement, or that no prior implant exists and records are being misread).
• Operative and imaging records confirming the current clinical situation (e.g., no prior device on imaging if the denial is based on a records error).

## Criteria-Mapping Structure

Copy each requirement listed in Cigna's coverage policy and the FDA-approved labeling into a two-column table. In the right column, cite the specific chart note, test result, or physician statement that satisfies each requirement. This direct mapping is the most persuasive element of a quantity-limit appeal because it forces the reviewer to address each criterion individually rather than relying on a blanket limitation.